Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Amortizatization of Intangibles (2016 - 2017)

Bone Biologics (BBLG) has disclosed Amortizatization of Intangibles for 2 consecutive years, with $1.2 million as the latest value for Q4 2017.

  • On a quarterly basis, Amortizatization of Intangibles fell 13.85% to $1.2 million in Q4 2017 year-over-year; TTM through Dec 2017 was $3.3 million, a 86.07% increase, with the full-year FY2018 number at $340735.0, down 89.76% from a year prior.
  • Amortizatization of Intangibles was $1.2 million for Q4 2017 at Bone Biologics, up from $935662.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.4 million in Q4 2016 to a low of $117726.0 in Q1 2016.